Skip to main content

Table 2 Mean FTP radiation dose estimates for the intervention group (mSv/MBq, n = 4)

From: Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride

Target organ

Mean

Standard deviation

Adrenals

1.34E−02

8.91E−04

Brain

4.37E−03

7.43E−04

Breast

6.11E−03

6.25E−04

Gallbladder wall

1.25E−01

8.41E−02

Lower large intestine wall

5.04E−02

1.12E−02

Small intestine

1.32E−01

3.19E−02

Stomach wall

1.40E−02

4.80E−04

Upper large intestine wall

1.51E−01

3.63E−02

Heart wall

1.93E−02

2.17E−03

Kidneys

2.57E−02

3.58E−03

Liver

5.76E−02

8.28E−03

Lungs

2.93E−02

1.22E−02

Muscle

8.84E−03

1.49E−04

Ovaries

2.70E−02

4.78E−03

Pancreas

1.54E−02

9.68E−04

Red marrow

1.04E−02

5.51E−04

Osteogenic cells

1.02E−02

3.39E−04

Skin

5.37E−03

1.96E−04

Spleen

3.09E−02

1.11E−02

Testes

5.84E−03

2.15E−04

Thymus

7.03E−03

7.49E−04

Thyroid

5.43E−03

4.62E−04

Urinary bladder wall

1.57E−02

4.16E−03

Uterus

2.14E−02

3.07E−03

Total body

1.22E−02

3.92E−04

Effective dose equivalent

4.40E−02

2.48E−03

Effective dose

2.67E−02

3.13E−03